Bio-Rad Laboratories BIO Free cash flow

Free cash flow at other companies

AbbottABT

$1.99B+28.9%

Becton, Dickinson and CompanyBDX

$633M-54.7%

Thermo Fisher ScientificTMO

$923M-16.5%

DanaherDHR

$1.27B+16.1%

MaxCyteMXCT

-$8.24M+45.3%

Quanterix CorporationQTRX

-$18.19M-20.1%

FAQ

What is Bio-Rad Laboratories's free cash flow?

Bio-Rad Laboratories (BIO) reported free cash flow of $78.1M in Q1 2026.

How has Bio-Rad Laboratories's free cash flow changed year-over-year?

Bio-Rad Laboratories's free cash flow decreased by 18.2% year-over-year, from $95.5M to $78.1M.

What is the long-term trend for Bio-Rad Laboratories's free cash flow?

Over 3 years (2021 to 2025), Bio-Rad Laboratories's free cash flow has grown at a -11.2% compound annual growth rate (CAGR), from $535.72M to $374.6M.

What does free cash flow mean?

Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.